Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV – Get Free Report)’s share price shot up 11.1% during trading on Monday . The stock traded as high as $1.00 and last traded at $1.00. 317 shares changed hands during mid-day trading, a decline of 67% from the average session volume of 949 shares. The stock had previously closed at $0.90.
Mosaic ImmunoEngineering Trading Up 11.1 %
The company has a market capitalization of $7.24 million, a PE ratio of -5.88 and a beta of 0.01. The business’s 50-day simple moving average is $0.92 and its 200-day simple moving average is $0.72.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last posted its quarterly earnings results on Wednesday, August 14th. The company reported ($0.04) earnings per share (EPS) for the quarter.
Mosaic ImmunoEngineering Company Profile
Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.
Further Reading
- Five stocks we like better than Mosaic ImmunoEngineering
- How to Use the MarketBeat Stock Screener
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
